Anton Schwaighofer
Research Subjects
Anton Schwaighofer has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Antonius ter Laak
Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, Berlin 13353, Germany
2 shared publications - Klaus-Robert Müller
Technische Universität Berlin
2 shared publications Nikolaus Heinrich
Fraunhofer FIRST, Kekuléstraße 7, 12489 Berlin, Germany, Technische Universität Berlin, Department of Computer Science, Franklinstraße 28/29, 10587 Berlin, Germany, idalab GmbH, Sophienstraße 24, 10178 Berlin, Germany, and Research Laboratories of Bayer Schering Pharma, Müllerstraße 178, 13342 Berlin, Germany
2 shared publicationsSebastian Mika
Fraunhofer FIRST, Kekuléstraße 7, 12489 Berlin, Germany, Technische Universität Berlin, Department of Computer Science, Franklinstraße 28/29, 10587 Berlin, Germany, idalab GmbH, Sophienstraße 24, 10178 Berlin, Germany, and Research Laboratories of Bayer Schering Pharma, Müllerstraße 178, 13342 Berlin, Germany
2 shared publicationsTimon Schroeter
Fraunhofer FIRST, Kekuléstraße 7, 12489 Berlin, Germany, Technische Universität Berlin, Department of Computer Science, Franklinstraße 28/29, 10587 Berlin, Germany, idalab GmbH, Sophienstraße 24, 10178 Berlin, Germany, and Research Laboratories of Bayer Schering Pharma, Müllerstraße 178, 13342 Berlin, Germany
2 shared publicationsAndreas Reichel
Fraunhofer FIRST, Kekuléstraße 7, 12489 Berlin, Germany, Technische Universität Berlin, Department of Computer Science, Franklinstraße 28/29, 10587 Berlin, Germany, idalab GmbH, Sophienstraße 24, 10178 Berlin, Germany, and Research Laboratories of Bayer Schering Pharma, Müllerstraße 178, 13342 Berlin, Germany
1 shared publication
Latest Publications
- 8 March 2008
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 48 (4) , 785-796
A Probabilistic Approach to Classifying Metabolic Stability
Metabolic stability is an important property of drug molecules that should-optimally-be taken into account early on in the drug design process. Along with numerous medium- or high-throughput assays being implemented in early drug discovery, a prediction tool for this property could be of high value. However, metabolic stability is inherently difficult to predict, and no commercial tools are available for this purpose. In this work, we present a machine learning approach to predicting metabolic stability that is tailored to compounds from the drug development process at Bayer Schering Pharma. For four different in vitro assays, we develop Bayesian classification models to predict the probability of a compound being metabolically stable. The chosen approach implicitly takes the "domain of applicability" into account. The developed models were validated on recent project data at Bayer Schering Pharma, showing that the predictions are highly accurate and the domain of applicability is estimated correctly. Furthermore, we evaluate the modeling method on a set of publicly available data.
- 8 March 2008
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 48 (4) , 785-796
A Probabilistic Approach to Classifying Metabolic Stability
Metabolic stability is an important property of drug molecules that should-optimally-be taken into account early on in the drug design process. Along with numerous medium- or high-throughput assays being implemented in early drug discovery, a prediction tool for this property could be of high value. However, metabolic stability is inherently difficult to predict, and no commercial tools are available for this purpose. In this work, we present a machine learning approach to predicting metabolic stability that is tailored to compounds from the drug development process at Bayer Schering Pharma. For four different in vitro assays, we develop Bayesian classification models to predict the probability of a compound being metabolically stable. The chosen approach implicitly takes the "domain of applicability" into account. The developed models were validated on recent project data at Bayer Schering Pharma, showing that the predictions are highly accurate and the domain of applicability is estimated correctly. Furthermore, we evaluate the modeling method on a set of publicly available data.
- 23 January 2007
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 47 (2) , 407-424
Accurate Solubility Prediction with Error Bars for Electrolytes: A Machine Learning Approach
Accurate in silico models for predicting aqueous solubility are needed in drug design and discovery and many other areas of chemical research. We present a statistical modeling of aqueous solubility based on measured data, using a Gaussian Process nonlinear regression model (GPsol). We compare our results with those of 14 scientific studies and 6 commercial tools. This shows that the developed model achieves much higher accuracy than available commercial tools for the prediction of solubility of electrolytes. On top of the high accuracy, the proposed machine learning model also provides error bars for each individual prediction.
- 23 January 2007
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 47 (2) , 407-424
Accurate Solubility Prediction with Error Bars for Electrolytes: A Machine Learning Approach
Accurate in silico models for predicting aqueous solubility are needed in drug design and discovery and many other areas of chemical research. We present a statistical modeling of aqueous solubility based on measured data, using a Gaussian Process nonlinear regression model (GPsol). We compare our results with those of 14 scientific studies and 6 commercial tools. This shows that the developed model achieves much higher accuracy than available commercial tools for the prediction of solubility of electrolytes. On top of the high accuracy, the proposed machine learning model also provides error bars for each individual prediction.